These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22575233)

  • 1. Cognitive and olfactory deficits in Machado-Joseph disease: a dopamine transporter study.
    Braga-Neto P; Felicio AC; Hoexter MQ; Pedroso JL; Dutra LA; Alessi H; Minett T; Santos-Galduroz RF; da Rocha AJ; Garcia LA; Bertolucci PH; Bressan RA; Barsottini OG
    Parkinsonism Relat Disord; 2012 Aug; 18(7):854-8. PubMed ID: 22575233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine transporter concentration is reduced in asymptomatic Machado-Joseph disease gene carriers.
    Yen TC; Tzen KY; Chen MC; Chou YH; Chen RS; Chen CJ; Wey SP; Ting G; Lu CS
    J Nucl Med; 2002 Feb; 43(2):153-9. PubMed ID: 11850478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive deficits in Machado-Joseph disease correlate with hypoperfusion of visual system areas.
    Braga-Neto P; Dutra LA; Pedroso JL; Felício AC; Alessi H; Santos-Galduroz RF; Bertolucci PH; Castiglioni ML; Bressan RA; de Garrido GE; Barsottini OG; Jackowski A
    Cerebellum; 2012 Dec; 11(4):1037-44. PubMed ID: 22307858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased dopamine transporter binding in Machado-Joseph disease.
    Yen TC; Lu CS; Tzen KY; Wey SP; Chou YH; Weng YH; Kao PF; Ting G
    J Nucl Med; 2000 Jun; 41(6):994-8. PubMed ID: 10855623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep disorders in Machado-Joseph disease: a dopamine transporter imaging study.
    Pedroso JL; Braga-Neto P; Felício AC; Minett T; Yamaguchi E; Prado LB; Carvalho LB; Dutra LA; Hoexter MQ; da Rocha AJ; Bressan RA; Prado GF; Barsottini OG
    J Neurol Sci; 2013 Jan; 324(1-2):90-3. PubMed ID: 23137414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine transporter density may be associated with the depressed affect in healthy subjects.
    Newberg A; Amsterdam J; Shults J
    Nucl Med Commun; 2007 Jan; 28(1):3-6. PubMed ID: 17159542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine transporter binding in chronic manganese intoxication.
    Huang CC; Weng YH; Lu CS; Chu NS; Yen TC
    J Neurol; 2003 Nov; 250(11):1335-9. PubMed ID: 14648150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantia nigra echogenicity is correlated with nigrostriatal impairment in Machado-Joseph disease.
    Pedroso JL; Bor-Seng-Shu E; Felício AC; Braga-Neto P; Hoexter MQ; Teixeira MJ; Bressan RA; Barsottini OG
    Parkinsonism Relat Disord; 2013 Aug; 19(8):742-5. PubMed ID: 23680416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between the availability of dopamine transporter and olfactory function in healthy subjects.
    Pak K; Kim K; Lee MJ; Lee JM; Kim BS; Kim SJ; Kim IJ
    Eur Radiol; 2018 Apr; 28(4):1756-1760. PubMed ID: 29164380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorodopa and raclopride PET analysis of patients with Machado-Joseph disease.
    Shinotoh H; Thiessen B; Snow BJ; Hashimoto S; MacLeod P; Silveira I; Rouleau GA; Schulzer M; Calne DB
    Neurology; 1997 Oct; 49(4):1133-6. PubMed ID: 9339702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degenerative parkinsonism in patients with psychogenic parkinsonism: A dopamine transporter imaging study.
    Felicio AC; Godeiro-Junior C; Moriyama TS; Shih MC; Hoexter MQ; Borges V; Silva SM; Aguiar Pde C; Andrade LA; Bressan RA; Ferraz HB
    Clin Neurol Neurosurg; 2010 May; 112(4):282-5. PubMed ID: 20061077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating dopamine transporter activity with 99mTc-TRODAT-1 SPECT in drug-naive Tourette's adults.
    Yeh CB; Lee CH; Chou YH; Chang CJ; Ma KH; Huang WS
    Nucl Med Commun; 2006 Oct; 27(10):779-84. PubMed ID: 16969259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairments in Machado-Joseph disease.
    Kawai Y; Takeda A; Abe Y; Washimi Y; Tanaka F; Sobue G
    Arch Neurol; 2004 Nov; 61(11):1757-60. PubMed ID: 15534186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary study of dopamine transporter binding in bipolar and unipolar depressed patients and healthy controls.
    Amsterdam JD; Newberg AB
    Neuropsychobiology; 2007; 55(3-4):167-70. PubMed ID: 17657170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related loss of olfactory sensitivity: association to dopamine transporter binding in putamen.
    Larsson M; Farde L; Hummel T; Witt M; Lindroth NE; Bäckman L
    Neuroscience; 2009 Jun; 161(2):422-6. PubMed ID: 19348872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease.
    Siderowf A; Newberg A; Chou KL; Lloyd M; Colcher A; Hurtig HI; Stern MB; Doty RL; Mozley PD; Wintering N; Duda JE; Weintraub D; Moberg PJ
    Neurology; 2005 May; 64(10):1716-20. PubMed ID: 15911797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance spectroscopy of the cerebellum in patients with spinocerebellar ataxia type 3/Machado-Joseph disease.
    Lei L; Liao Y; Liao W; Zhou J; Yuan Y; Wang J; Jiang H; Shen L; Tang B
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):511-9. PubMed ID: 21743142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced striatal dopamine transporter density associated with working memory deficits in opioid-dependent male subjects: a SPECT study.
    Liang CS; Ho PS; Yen CH; Yeh YW; Kuo SC; Huang CC; Chen CY; Shih MC; Ma KH; Huang SY
    Addict Biol; 2016 Jan; 21(1):196-204. PubMed ID: 25439653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography of striatal serotonin transporters in Parkinson disease.
    Kerenyi L; Ricaurte GA; Schretlen DJ; McCann U; Varga J; Mathews WB; Ravert HT; Dannals RF; Hilton J; Wong DF; Szabo Z
    Arch Neurol; 2003 Sep; 60(9):1223-9. PubMed ID: 12975287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal dopamine transporter binding correlates with serum BDNF levels in patients with striatal dopaminergic neurodegeneration.
    Ziebell M; Khalid U; Klein AB; Aznar S; Thomsen G; Jensen P; Knudsen GM
    Neurobiol Aging; 2012 Feb; 33(2):428.e1-5. PubMed ID: 21176997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.